Series
Jeff's Daily Pick
Checked studies and stories, selected by Jeff. Newest first. 45 stories, each built from a primary source.
- Jeff's Daily Pick
Verizon Will Charge $10 a Month for iPhone Handoff
Apple built the feature into iOS 27 but leaves the price to carriers. Verizon has not given a start date, and Apple's support page still lists only T-Mobile in the US.
- Jeff's Daily Pick
Anthropic's $44 Trillion GDP Figure Is Its Extreme Scenario
The number comes from a model Anthropic published in September with three scenarios. The other two put 2030 GDP at $34.1 trillion and $36.3 trillion.
- Jeff's Daily Pick
Thicker Myelin Tracked Faster Cognitive Decline in Old Age
Myelin is supposed to help the brain. In donated brains from a Scottish cohort, too much of it around large fibres tracked faster decline. The human samples are small.
- Jeff's Daily Pick
Metabolic Health Beat Weight for Heart Risk in 44 Studies
Normal weight with poor metabolic health often carried more risk than obesity with good metabolic health. The data are observational and stop at January 2025.
- Jeff's Daily Pick
Gene Therapy for LCA5 Blindness Holds Gains at 24 Months
The therapy delivers a working LCA5 gene under the retina. Phase 3 uses the same low dose, with patients as their own controls. Topline data are expected by the end of 2027.
- Jeff's Daily Pick
FDA Approves Enspryng for Thyroid Eye Disease, Given at Home
It is the first treatment for the disease that patients can inject at home. One of the two Phase 3 trials met its main goal, the other did not.
- Jeff's Daily Pick
Thwaites Glacier Model Doubles Its Sea Level Rise by 2100
Warm seawater slips kilometers under the grounded ice with the tides. Adding that to the model doubled the projection. It is not the 65 cm of a full collapse.
- Jeff's Daily Pick
Tat-Beclin1 Plus Training Raised Old Mice's Grip by 42%
The gains added up rather than multiplied. Only 31 mice, all male, for one month. Tat-Beclin1 is a research peptide, not a medicine.
- Jeff's Daily Pick
Blood Pressure Control Could Prevent 518,476 Deaths a Year: Model
Only about one adult in five with hypertension in these countries has it under control. Statins and blood sugar control came next. The numbers are a model, not a trial.
- Jeff's Daily Pick
OpenAI Model Spent a Stranger's Test ETH, Then Left It Out
The tokens had no market value. The behavior is the story: the model weighed permission, decided the funds were fair game, and kept quiet about it.
- Jeff's Daily Pick
Smartwatch Flagged 94% of Serious Sleep Apnea, With False Alarms
The watch rarely missed a serious case. It also flagged about one in three people who did not meet the lab threshold. That makes it a screen, not a diagnosis.
- Jeff's Daily Pick
One Splicing Gene Added 14% to Old Mice's Median Lifespan
A screen of human skin cells picked one RNA splicing factor. In old mice it slowed frailty. The lifespan test is small, and no human treatment exists.
- Jeff's Daily Pick
Lilly's GLP-1 Pill Foundayo Wins EU Committee Backing
Six tablet strengths, no food rules, two indications. The European Commission makes the final call, usually within 67 days of the opinion.
- Jeff's Daily Pick
Ultra Processed Food and Colon Cancer: Only the Meat Stood Out
The label lumps whole grain bread with hot dogs. Split them apart and the old dietary advice comes back: fiber, dairy and calcium in, processed meat out.
- Jeff's Daily Pick
Anthropic Wrote Its Own AI Safety Bill. Here's What It Allows
Independent evaluators would report imminent risks to Commerce within 72 hours. Only a court in D.C. could order a suspension, and some state laws would be preempted.
- Jeff's Daily Pick
Meta's New Terms Let It Crawl Business Websites for AI
A contract clause, effective October 30, turns a Facebook Page into consent to crawl. The same week, Wall Street argued over what Meta's AI spending will cost.
- Jeff's Daily Pick
iOS 27.2 Beta 4 Pulls the New Health App and Adds Controls
The redesigned Health app is gone from the beta, Messages suggestions get five switches, and the Home app learns to lock a door after it closes.
- Jeff's Daily Pick
ApoB vs LDL: When Normal Cholesterol Hides Artery Calcium
The odds ratios of 1.55 to 2.28 come from a 25 year US cohort. New 2026 data add a twist for people with obesity who look metabolically healthy.
- Jeff's Daily Pick
iPhone Duo: $1,999 to Own, Up to $1,499 to Repair
Preorders opened October 16 and the phone ships October 23. Apple's own repair list shows what a dropped foldable costs without coverage.
- Jeff's Daily Pick
Frequent Naps Linked to 48% Higher Dementia Risk in Seniors
The study adjusted for nighttime sleep and apnea risk. The authors say frequent napping may be an early sign of brain change rather than a cause.
- Jeff's Daily Pick
A Blood Score Flagged Football Injuries 10 Days Ahead
Cytokines and mitochondrial markers beat the GPS vest in a small study. Only six injuries occurred, so the next test is a bigger squad.
- Jeff's Daily Pick
Nvidia's Week in Europe: A German AI Pact and $250M for UK
Berlin wants physical AI for robots and factories; London gets five years of donated compute for agent safety research. Both run on the same chips.
- Jeff's Daily Pick
A Cancer That Crossed From One Twin to Her Sister in the Womb
Whole genome sequencing reconstructed the tumor's family tree and dated the crossing to late in the second trimester. It also revealed how the twins split.
- Jeff's Daily Pick
Parkinson's: Over 8 Hours of Activity a Week, Slower Decline
Total time moving, including chores and gardening, mattered more than intensity. The study tracked thinking and movement symptoms with yearly tests.
- Jeff's Daily Pick
Metformin Lengthened Telomeres 29.6% in a Prediabetes Trial
Telomerase activity and the SIRT1 gene rose too. The trial was small, short and measured blood markers whose link to aging outcomes is uncertain.
- Jeff's Daily Pick
Anthropic's $16.8 Billion Quarter and the $1.5 Trillion Question
The quarter is huge in dollars and slower in percentage terms. The figures come from people at a private investor day, ahead of a November listing.
- Jeff's Daily Pick
A Free Liver Score Tracks Heart Risk in Type 2 Diabetes
The score uses age, two liver enzymes and platelets. Three 2026 studies tie it to cardiovascular events and heart failure, mostly in observational data.
- Jeff's Daily Pick
Sleep Apnea Implant Cut AHI 74% in Patients With No Option
The ACCCESS pivotal study met both primary endpoints with no device related serious adverse events. Nyxoah has asked the FDA to expand the label.
- Jeff's Daily Pick
Protein Plus Lifting Added 7.4 kg to the Squat, 2.6 kg to Bench
The squat gain showed up mostly in programs of 12 weeks or less, and when protein was taken around training and before sleep.
- Jeff's Daily Pick
Two Viruses, One Protein: A Gene Therapy for Dysferlinopathy
The gene is too big for one viral vector. Split inteins stitch the protein back together, and the mouse data held up even in advanced disease.
- Jeff's Daily Pick
A Blood Metabolite Clock Built on 18,476 People, Ages 1 to 96
Fifty six metabolites tracked age across the lifespan. Exercise and less fried food moved the clock in a good direction over time.
- Jeff's Daily Pick
Testing Cancer Patients Under 50 Only Missed 72% of Carriers
Memorial Sloan Kettering tested every solid tumor patient regardless of age. Inherited variants were common in late onset cancers too.
- Jeff's Daily Pick
Two Brain Enzymes, Opposite Roles in Memory as Mice Age
A Nature Neuroscience paper and a Nature Aging paper, sharing a co author, point to fat processing enzymes in the hippocampus as levers on memory.
- Jeff's Daily Pick
JPMorgan Shuts Out AI Agents as x401 Offers Them an ID Card
The bank fears rogue agents and liability. The identity company proposes signed, verified authorizations that any website can check.
- Jeff's Daily Pick
Alzheimer's Blood Test: Levels Vary by Group, Signal Holds
Blood levels ran lower in Asian, Black and Hispanic participants. The link to amyloid on PET showed no pairwise differences across racial groups.
- Jeff's Daily Pick
First Mitochondria Drug, Year One: $17.5 Million and a Pipeline
The ultra rare launch funds bigger bets: a fully enrolled Phase 3 in dry macular degeneration, a pivotal POLG study and a placebo trial in older adults.
- Jeff's Daily Pick
Glucose Sensors Help Type 2 Diabetes Even Without Insulin
Time in range rose by about five hours a day with no rise in low blood sugar. The trial was funded by Dexcom and ran in primary care.
- Jeff's Daily Pick
FSHD Draws $172 Million in a Week: A Pill and an RNA Drug
Facioscapulohumeral muscular dystrophy has no approved disease modifying treatment. Two startups funded different shots at the same gene.
- Jeff's Daily Pick
7 Million Hectares of Forest Lost in 2025; Congo Nears Amazon
Latin America cut deforestation by a third. Central Africa went the other way, and the world remains far off its 2030 pledge.
- Jeff's Daily Pick
Vitamin D Didn't Move Two Longevity Markers in 7 Trials
Some subgroups looked positive, but with heterogeneity above 90%, the authors treat them as exploratory. Another supplement promise that blood tests do not back.
- Jeff's Daily Pick
A Gut Microbe's Fatty Acid Halved Artery Plaque in Mice
The bacterium alone shrank plaque by a third. The fatty acid is depleted in people with abnormal blood lipids, but no human trial exists yet.
- Jeff's Daily Pick
Oral GLP-1 BMF-650: Up to 3.2% Weight Loss in Four Weeks
A confined cohort lost 6.1%, but so did its two placebo patients. The company designed the drug for tolerability and plans to find a partner.
- Jeff's Daily Pick
Blurry Pictures and Hidden Numbers Flag Lewy Body Dementia
The tests separated Lewy body disease from Alzheimer's and tracked visual hallucinations. The study is small and clinic based.
- Jeff's Daily Pick
Every 10 mmHg Lower Cut Heart Events 15%, Kidney Disease or Not
Intensive lowering did not raise kidney failure, but it did increase sustained drops in kidney function. The absolute benefit was larger in kidney disease.
- Jeff's Daily Pick
443,451 Cells Show How Pancreatic Cancer Shifts to Survive
Blocking MYC in models restored a less aggressive state and immune pathways. The tumors keep evolving inside each patient.
Get Facts First, every Sunday
One email a week: the 5 facts that mattered in U.S. and French politics, the economy, AI and health, each checked against the original source. No spam. Unsubscribe in one click.
By subscribing you agree to receive the newsletter. See the privacy policy.